Smith & Nephew plc
NYSE:SNNMedical - Devices
-$0.43 today
- Market cap
- $12.72B
- Beta
- 0.67
- P/E (TTM)
- 20.1
- EPS (TTM)
- $0.74
- Dividend yield
- 2.59%
Volume 1.22M
Average 1.10M
SNN Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Smith & Nephew plcNYSE: SNN
Cash & Equivalents · Q4 FY2025 · quarter ended Dec 2025
Cash & equivalents falls 10.0% from a year ago
Cash & equivalents stood at $557M at the end of Q4 FY2025, down 10.0% from a year earlier. Over 3 fiscal years it compounded at +16.8% a year.
Context
- Cash & equivalents amounted to 5.3% of total assets at the end of Q4 FY2025, down 0.7 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -10.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 557M USD
- Year-over-year change
- -10.0%
- 4-year CAGR
- -18.9%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 557M | -10.0% |
| FY2024 | 2024-12-31 | 619M | +105.0% |
| FY2023 | 2023-12-31 | 302M | -13.7% |
| FY2022 | 2022-12-31 | 350M | -72.9% |
| FY2021 | 2021-12-31 | 1.29B | — |
Cash & Equivalents vs competitors
How SNN compares with its peers on the latest reported figures
- SNN's Dec 2025 cash & equivalents of $557M is the 2nd highest of the 11 companies compared; the peer median is $130.1M.
- Its year-over-year change of -10.0% is the 8th highest of 11, against a peer median of -1.1%.
- Cash & equivalents amounts to 5.3% of total assets for SNN, versus a peer median of 6.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $3.39B | +42.8% | +29.6% | 7.1% | |
| Dec 2025 | $557M | -10.0% | +16.8% | 5.3% | |
| Jun 2026 | $507.75M | +121.3% | +51.8% | 9.3% | |
| Jun 2026 | $410M | -26.4% | +16.4% | 1.8% | |
| Mar 2026 | $236.81M | -1.0% | -19.9% | 6.6% | |
| Mar 2026 | $139.91M | -8.7% | +23.8% | 17.5% | |
| Mar 2026 | $120.28M | +107.5% | +17.4% | 13.6% | |
| Mar 2026 | $35.03M | -1.3% | +12.1% | 1.5% | |
| Apr 2026 | $33.13M | -13.9% | +14.4% | 0.9% | |
| Mar 2026 | $14.25M | -57.4% | +29.6% | 2.8% | |
| Mar 2026 | $12.16M | +141.6% | -5.6% | 15.6% | |
| Peer median (excluding SNN) | $130.1M | -1.1% | +16.9% | 6.8% | |
Competitors are the stored peer set for SNN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.29B | 350M | 302M | 619M | 557M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 971M | 1.03B | 1.06B | 1.21B | 1.43B |
| Inventory | 1.84B | 2.21B | 2.4B | 2.39B | 2.12B |
| Other Current Assets | 240M | 198M | 182M | 81M | (99M) |
| Total Current Assets | 4.42B | 3.86B | 4.03B | 4.42B | 4.1B |
| Property, Plant & Equipment (Net) | 1.51B | 1.46B | 1.47B | 1.42B | 1.64B |
| Goodwill | 2.99B | 3.03B | 2.99B | 3.03B | 3.11B |
| Intangible Assets | 1.4B | 1.24B | 1.11B | 1.03B | 882M |
| Long-term Investments | 380M | 58M | 24M | 16M | 151M |
| Tax Assets | 201M | 177M | 274M | 334M | 347M |
| Other Non-current Assets | 15M | 153M | 87M | 103M | 228M |
| Total Non-current Assets | 6.5B | 6.11B | 5.96B | 5.93B | 6.35B |
| Total Assets | 10.92B | 9.97B | 9.99B | 10.35B | 10.46B |
| Account Payables | 1.04B | 1.03B | 1.02B | 1.08B | 1.16B |
| Short-term Debt | 435M | 111M | 710M | 2M | 83M |
| Tax Payables | 222M | 214M | 218M | 232M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 597M | 526M | 261M | 126M | 85M |
| Total Current Liabilities | 2.13B | 1.72B | 2.27B | 1.53B | 1.6B |
| Long-term Debt | 2.71B | 2.57B | 2.18B | 3.12B | 3.03B |
| Deferred Tax Liabilities | 144M | 36M | 9M | 31M | 40M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 229M | 244M | 171M | 269M | 356M |
| Total Non-current Liabilities | 3.22B | 2.99B | 2.5B | 3.56B | 3.57B |
| Total Liabilities | 5.35B | 4.71B | 4.77B | 5.09B | 5.17B |
| Common Stock | 177M | 175M | 175M | 175M | 175M |
| Retained Earnings | 5.23B | 5.03B | 4.91B | 5.02B | 5.32B |
| Accumulated OCI | (328M) | (439M) | (385M) | 0 | 20M |
| Other Stockholders Equity | 0 | 0 | 0 | (497M) | (329M) |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 5.57B | 5.26B | 5.22B | 5.27B | 5.29B |
| Total Debt | 3.34B | 2.87B | 3.08B | 3.32B | 3.33B |
| Net Debt | 2.05B | 2.52B | 2.78B | 2.7B | 2.77B |
Smith & Nephew plc
NYSE:SNN
Intrinsic Alpha fair value
Locked
Current Price
$30.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.